The Russian developers of a coronavirus vaccine have developed immunity to the infection after self-administering it, Interfax reported Friday.
Scientists at the Gamaleya Research Center for Epidemiology and Microbiology “aren’t so much testing as protecting themselves to continue working,” its head Alexander Gintsburg told the news agency.
“Everyone’s alive, healthy and happy,” Gintsburg said when asked if the vaccine developers experienced any side effects. “As such, everyone involved in development is protected.”
Gintsburg did not say how many people took the vaccine, which uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response. He identified the test subjects only as a “wide range” of developers, preclinical researchers and technologists.
The research center is awaiting the results of monkey trials in order to seek permission from the Health Ministry to begin clinical trials on humans, Gintsburg said.
With 326,448 reported infections, Russia has the world’s second-highest number of coronavirus cases behind the United States.